Know Before You Launch: The Complete Step-by-Step Guide to Freedom-to-Operate Analysis in Pharma
Launching a drug without a freedom-to-operate analysis is like building a factory on land you haven’t verified you own. You […]
Business Development Guide for Commercial & Market Access Vendors: Sell Before the Drug Patent Clock Runs Out
How to Win Biopharma Contracts by Entering the Deal Before Generic Entry Does Why Timing Is the Only Thing That
Drug Patents in Asia-Pacific: A Country-by-Country Guide to How Long Protection Actually Lasts
The Number Every Pharma Strategist Gets Wrong Ask a pharmaceutical executive how long a drug patent lasts in Asia-Pacific, and
Paragraph IV Filings: The Procurement Due Diligence Tool Most Pharma Buyers Ignore
How generic drug suppliers’ litigation histories expose supply chain risk, financial fragility, and competitive staying power — before you sign
Paragraph IV Filings: The Procurement Due Diligence Tool Most Pharma Buyers Ignore Read Post »
Turn Drug Patent Expiry Dates Into Your Next Sales Campaign
A practical playbook for formulation vendors, CDMOs, and excipient suppliers on how to mine patent loss-of-exclusivity data to find, time,
Turn Drug Patent Expiry Dates Into Your Next Sales Campaign Read Post »
Sell the Line Before the Patent Breaks: A Business Development Guide for Solid Dose Equipment & Manufacturing Technology Suppliers Targeting Pre-LOE Generic Expansion
The $200 Billion Window Nobody in Sales Talks About Between 2025 and 2030, an estimated $200 billion in annual branded
The Smarter Monopoly: Orphan Drug Exclusivity vs. Standard Drug Patents
How rare disease drugmakers build market protection that no generic can touch — and what every analyst needs to know
The Smarter Monopoly: Orphan Drug Exclusivity vs. Standard Drug Patents Read Post »
Sell Before the Cliff: A Business Development Playbook for Sterile Manufacturing Suppliers Targeting Biologic Loss of Exclusivity
The Patent Cliff Is Not an Event. It’s a Calendar. Every biologic drug that ever earned blockbuster status is on
Drug Switching Questions: What Patients Are Really Asking Online
Across hundreds of DrugChatter queries, a clear pattern emerges: patients and caregivers are not just asking about drugs—they’re asking what
Drug Switching Questions: What Patients Are Really Asking Online Read Post »
